Asuragen's Series D Round

Asuragen raised a round of funding on March 20, 2013.

Asuragen is a fully integrated molecular diagnostics company focused on oncology and companion diagnostics with special capabilities in the area of mRNA and miRNA. Based in Austin, Texas, the company …

Articles about Asuragen's Series D Round: